Influenza virus vaccine (split virion, inactivated)

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Influenza

Phase 3

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)

CompletedNCT01121822

Sanofi Pasteur, a Sanofi CompanyInfluenza

Start: 2010-05-31End: 2010-06-30Updated: 2015-10-06

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

CompletedNCT01138397

Sanofi Pasteur, a Sanofi CompanyInfluenza

Start: 2010-06-30End: 2010-07-31Updated: 2015-10-06